Burnett / Doyle / Hrycyna / Daniel / Rabindran / Paris / Brea / Ibaraki / Multivariate / Claix / Reims Cedex / San Diego / /
Company
SAS Institute Inc. / Borg AG / Proc Natl Acad Sci U S A / Beckman Coulter / Becton Dickinson / Oncology Group / Cox / recorded using a Beckman Coulter / /
Country
France / Japan / / /
Event
FDA Phase / /
Facility
Banyu Tsukuba Research Institute / Stanford University / / /
MedicalCondition
adult acute myeloid leukemia / JE / myelodysplastic syndromes / human cancers / acute myeloid leukemia MRP3 / clinically resistant disease / leukaemia / lung large cell carcinoma / Acute promyelocytic leukemia / childhood ALL / infant acute lymphoblastic leukemia / leukemias / breast cancer / acute monocytic leukemia / erythroleukemia / dissociation / Leukemia / acute myeloid leukemias / Cancer / disease / acute leukemia / sur le Cancer / acute lymphoblastic leukemia / human myeloid leukemia / acute myeloid leukemia / T acute lymphoblastic leukemia / /
UK MRC / World Health Organization / Federal Trade Commission / Banyu Tsukuba Research Institute / NS NS / NS WHO / American Society of Hematology / Stanford University / Pharmacology Department / American Association for Cancer Research / /
Imaging, Diagnosis, Prognosis MRP3, BCRP, and P-Glycoprotein Activities are Prognostic Factors in Adult Acute Myeloid Leukemia Zineb Benderra,1 Anne Marie Faussat,1 Lydia Sayada,1 Jean-Yves Perrot,2 Ruoping Tang,1 Driss